| Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2013: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Outline of Final Research Achievements |
In a wound model of two-dimensional keratinocyte culture system and LSE, it was difficult to reproduce the bacterial infection model in the wound only with bacteria, keratinocyte, and antibacterial agents. The examination about the wound healing delay using the CRAMP knockout mise in vivo could not run, because continuous supply of Firmocidin from the colleague had been impossible. In vivo examination results may lead to the identification of desired cells. We wait for Firmocidin supply and are going to develop further examination continuously.
|
